Baltimore, MD (PRWEB) January 31, 2013
Lawsuits have been filed in the deaths of 11 dialysis patients in the following states: Georgia (1), Kentucky (1), Ohio (2), Virginia (1), Texas (3), Florida (1), Illinois (1) and California (1) alleging dosing errors associated with GranuFlo® or NaturaLyte®, two products recalled by manufacturer Fresenius Medical Care, the law firm of Janet, Jenner & Suggs, LLC, has announced.
Another lawsuit also has been filed in the serious and permanent cardiac injury of a California man, the law firm reported.
The deaths occurred between 2010 and 2012, and involved patients as young as 23 and as old as 89, the firm added. According to court documents, all of the patients died of a cardiac arrest or stroke or were injured during or shortly after receiving dialysis using one of the two solutions, which were urgently recalled last May for mixing and labeling problems.
“We are representing a large number of families who have been devastated by Fresenius’ failure to properly label its dialysis solutions, instruct doctors and clinic staff about how to mix them, and disclose what the company knew was a much higher risk of cardiac arrest associated with its products,” said medical device injury lawyer Robert K. Jenner.
“As described in our law suits, our investigations have shown that the company knew, or should have known, that confusion about how to properly mix these dialysis solutions was associated with a higher-than-expected rate of fatal heart events at its dialysis clinics,” he said. Fresenius is the largest operator of dialysis clinics in the United States and also manufactures dialysis solutions and equipment.
According to court documents, Fresenius’ internal documents showed the company had known since at least 2010 that 941 patients had suffered cardiac arrest after receiving GranuFlo® – a rate six times higher than competing products. The company notified doctors at its own clinics about the inappropriate dosing instructions in November 2011, however, it waited until March 29, 2012, to notify other clinics, and it didn’t issue an urgent recall of the products until late June, according to the documents and the Federal Drug Administration, as reported in the New York Times.
According to the FDA, GranuFlo® and NaturaLyte® have been linked to alkalosis, a condition caused by high levels of bicarbonate in the blood. Alkalosis has been associated with cardiovascular death and catastrophic heart injuries in patients undergoing dialysis treatment, the agency said.
Many of the lawsuits have been filed in Massachusetts because Fresenius is headquartered there, Jenner explained. Lawsuits have been filed in Massachusetts Superior Court, Commonwealth of Massachusetts, in the deaths of the following persons:
Dialysis patients who suffered heart attacks, sudden cardiac death, and other catastrophic heart side effects within 48 hours of a dialysis treatment with GranuFlo® or NaturaLyte® may be entitled to compensation for medical expenses, lost wages, pain and suffering, and more. To discuss a possible legal case involving GranuFlo® or Naturalyte®, contact Janet, Jenner & Suggs, LLC.
About Janet, Jenner & Suggs, LLC
The law firm of Janet, Jenner & Suggs, LLC, is a nationally recognized law firm representing victims of defective products, medical devices, prescription drugs and medical malpractice. Each of the firm’s principals is named in The Best Lawyers in America® and Super Lawyers®. The firm has offices in Baltimore, Maryland (Commerce Centre East, 1777 Reisterstown Road, Suite 165, Baltimore, MD 21208; local phone number (410) 653-3200); Boston, MA; Columbia, SC; and Asheville, NC. The firm accepts clients and referrals from clients and attorneys throughout the country. For more information contact the firm at (888) 463-3529.